At the 2019 Lymphoma & Myeloma Congress, Steven Treon, MD, PhD, FACP, FRCP, Harvard University, Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, Massachusetts, provided an update on the latest research in the treatment of Waldenström Macroglobulinemia.

For the past 18 years, the Lymphoma & Myeloma congress has been recognized around the world as the most respected forum for industry-leading hematologic research —it’s where interdisciplinary specialists convene to explore the controversial and the complex, the emerging and the exciting, and discuss, debate, and discover along the way.

In this segment, Dr. Steven Treon discusses new approaches to the treatment of Waldenstrom's Macroglobulinemia.


For more information on this congress, please visit https://lymphomaandmyeloma.oncnet.com/